TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · major macro event coming up
FATE

Fate Therapeutics Inc

Healthcare · Biotechnology

2.40$ +0.9% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

Fate Therapeutics Inc (FATE) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 260 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet FATE
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
544 506 570 529 495 441 399 372 344 319 285 260
364 332 394 319 310 292 248 230 221 209 180 158
33 42 121 37 38 36 45 41 41 47 40 32
350 315 384 305 297 279 240 223 215 204 175 154
1.5 1.8 0.9 1.0 4.1 3.5 2.4 1.4 0.7 0.9 0.7 0.7
0.0 – – -12 – – – – – – – –
141 138 144 132 133 122 110 110 110 112 105 107
41 39 45 35 37 39 28 29 28 36 31 33
6.0 6.2 6.4 6.6 6.9 7.4 6.5 5.7 4.8 4.6 4.7 4.9
5.7 4.7 6.8 5.5 6.3 9.4 4.2 4.0 3.5 2.7 3.3 3.3
403 368 426 397 362 319 288 261 234 207 180 153
-1,168 -1,212 -1,260 -1,298 -1,346 -1,398 -1,436 -1,470 -1,502 -1,534 -1,566 -1,596
99 99 101 117 118 118 118 119 119 119 120 120

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?